Publicacions
-
Colomer J, Müller JS, Vernet A, Nascimento-Osorio A, Pons-Odena M, Gonzalez V, Abicht A and Lochmüller H.
Long-term improvement of slow-channel congenital myasthenic syndrome with fluoxetine
NEUROMUSCULAR DISORDERS . 16(5): 329-333. Nº de cites: 33
-
Pineda M, Ormazabal-Herrero A, López-Gallardo E, Nascimento-Osorio A, Solano A, Herrero MD, Vilaseca MA, Briones P, Ibañez-Toda L, Montoya J and Artuch-Iriberri R.
Cerebral folate deficiency and leukoencephalopathy caused by a mitochondrial DNA deletion
ANNALS OF NEUROLOGY . 59(2): 394-398. Nº de cites: 98
-
Nascimento-Osorio A, Navarro, R, Colomer J, Gómez, F and Sola-Martinez T.
Síndrome de Moyamoya asociado al síndrome de Down. Hallazgos clínicos y radiológicos
SD, Revista Medica Internacional sobre el Sindrome de Down . 10(3): 41-45.
-
Montero-Sanchez R, Artuch-Iriberri R, Briones P, Nascimento-Osorio A, Garcia-Cazorla A, Vilaseca MA, Sánchez-Alcázar JA, Navas P, Montoya J and Pineda M.
Muscle coenzyme Q10 concentrations in patients with probable and definite diagnosis of respiratory chain disorders
BIOFACTORS . 25(1-4): 109-115. Nº de cites: 39
-
Estévez-Arias B, Segarra-Casas A, Seoane P, Romo L, Polavarapu K, Nectoux J, Caballero-Ávila M, Austin-Tse C, Konyukh M, Obeid K, Hinderhofer K, Aksel-Kilicarslan O, Matalonga L, Rojano E, Ranea JA, O'Heir E, Singer-Berk M, O'Leary M, O'Donnell-Luria A, Spinazzi M, Verebi C, Leturcq F, Van Den Bergh P, Specht S, de Luna N, de Castro M, Roggenbuck J, Carrera-García L, Exposito-Escudero JM, Jou-Munoz C, Ortez-Gonzalez CI, Llansó L, Hernández-Laín A, Straub V, Gallano P, Nascimento-Osorio A, Evangelista T, Olivé M, Domínguez-González C, Lochmüller H, Malfatti E, Töpf A, Gallardo E, González-Quereda L and Natera-de Benito D.
A Recurrent 3'UTR Variant in CAPN3 Highlights the Diagnostic Impact of Non-Coding Variants in Limb-Girdle Muscular Dystrophies.
ANNALS OF NEUROLOGY . : .
-
Mendell JR, Muntoni F, McDonald CM, Mercuri EM, Deconinck N, Ciafaloni E, Komaki H, Leon-Astudillo C, Nascimento-Osorio A, Proud C, Schara-Schmidt U, Veerapandiyan A, Zaidman CM, Furgerson M, Asher DR, Vivien M, Sun Y, Murphy AP, Pordeli P, Torre CO, Manfrini M, Gerber M and Rodino-Klapac LR.
Three-Year Follow-Up of Delandistrogene Moxeparvovec in Duchenne Muscular Dystrophy: Long-Term Phase 3 EMBARK Trial Results.
Neurology and Therapy . : .